Market Cap (In CNY)
6.36 Billion
Revenue (In CNY)
4.46 Billion
Net Income (In CNY)
521.33 Million
Avg. Volume
2.83 Million
- Currency
- CNY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 11.34-17.45
- PE
- -
- EPS
- -
- Beta Value
- 0.223
- ISIN
- CNE100002VG4
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Zhenxin Du
- Employee Count
- -
- Website
- https://www.lkcisen.com
- Ipo Date
- 2017-09-29
- Details
- Cisen Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells chemical drug preparations and health care products in China and internationally. The company's chemical drug preparations include liver disease drugs, antitumor and auxiliary drugs, nutrition preparations, contrast agents, antibiotics, digestive system agents, polypropylene ampoules, and external preparations, as well as sedation anesthesia, cardiovascular, cough and asthma, immunomodulator, infusion, and therapeutic infusion products. The company was formerly known as Shandong Lukang Cisen Pharmaceutical Co., Ltd. and changed its name to Cisen Pharmaceutical Co., Ltd. in 2011. Cisen Pharmaceutical Co., Ltd. was founded in 1998 and is headquartered in Jining, the People's Republic of China.
More Stocks
-
JMT
-
NCI
-
AJBAJ Bell plc
AJB
-
OMEROMER S.p.A.
OMER
-
300081
-
SYNE3SYN prop e tech S.A.
SYNE3
-
000983
-
300845